Cargando…
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
Breast cancer remains the most frequent cancer in women with different patterns of disease progression and response to treatments. The identification of specific biomarkers for different breast cancer subtypes has allowed the development of novel targeting agents for imaging and therapy. To date, pa...
Autores principales: | Salvatore, Barbara, Caprio, Maria Grazia, Hill, Billy Samuel, Sarnella, Annachiara, Roviello, Giovanni Nicola, Zannetti, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826563/ https://www.ncbi.nlm.nih.gov/pubmed/31652624 http://dx.doi.org/10.3390/cancers11101614 |
Ejemplares similares
-
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
por: Sarnella, Annachiara, et al.
Publicado: (2020) -
Therapeutic Potential of a Novel α(v)β(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type
por: Hill, Billy Samuel, et al.
Publicado: (2019) -
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells
por: Sarnella, Annachiara, et al.
Publicado: (2023) -
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
por: Sarnella, Annachiara, et al.
Publicado: (2022) -
Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype
por: Hill, Billy Samuel, et al.
Publicado: (2017)